Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -20,100 | -16,740 | N/A | N/A |
| Depreciation Amortization | 1,787 | 1,467 | N/A | N/A |
| Other Working Capital | -397 | 3,469 | N/A | N/A |
| Other Operating Activity | 1,005 | 3,233 | 0 | 0 |
| Operating Cash Flow | $-17,705 | $-8,571 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,206 | -53 | N/A | N/A |
| Net Acquisitions | -197 | N/A | N/A | N/A |
| Investing Cash Flow | $-1,403 | $-53 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 567 | 8,095 | N/A | N/A |
| Common Stock Issued | 20 | 154 | N/A | N/A |
| Other Financing Activity | 34,866 | -27 | 0 | 0 |
| Financing Cash Flow | $35,453 | $8,222 | $N/A | $N/A |
| Beginning Cash Position | 251 | 653 | N/A | N/A |
| End Cash Position | 16,596 | 251 | N/A | N/A |
| Net Cash Flow | $16,345 | $-402 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -17,705 | -8,571 | N/A | N/A |
| Capital Expenditure | -1,206 | -53 | N/A | N/A |
| Free Cash Flow | -18,911 | -8,624 | 0 | 0 |